MDCX · Medicus Pharma Ltd.
$0.27
0.00 (-0.15%)
At close · Aug 21
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“This uncertainty, along with the Company's history of losses, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$17.17M
Shares
63.18M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.27
Open$0.27
Day$0.27–0.28
52W close$0.26–2.80
Avg vol 30d1.8M
Short int3.0M · 4.8% float · 1.8d
Short vol43%
DataNov 2024–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−69%
below
Price vs 50-day avg
−24%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
0%
near low
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−82%
trailing
YTD return
−82%
this year
Relative strength
−93%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.76% of float · ▲ +5.9% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
27 holders — near 1-yr high, broad support
Squeeze score
55
elevated · 0–100
Fundamentals
EPS growth
−136%
Y/Y
Balance sheet
$3.5M
net cash
Quant / Vol
risk profile
Volatility
127%
annualized · 1-yr
Max drawdown
−91%
past year
ATR
12.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−69%
Bearish
Price vs 50-day avg
−24%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+8% holders QoQ · +9 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.76% of float · ▲ +5.9% MoM · 1.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
27 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $3
vs 200-day avg -69%
vs 50-day avg -24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - General — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MDCX
this stock
Medicus Pharma Ltd.
|
$17.17M | -82.2% | — | — | 4.8% |
|
LLY
ELI LILLY & Co
|
$1.18T | +16.8% | +44.7% | 42.1 | 1.0% |
|
JNJ
Johnson & Johnson
|
$651.25B | +30.6% | +6.0% | 31.4 | 1.1% |
|
ABBV
AbbVie Inc.
|
$468.22B | +16.0% | +8.6% | 74.9 | 1.3% |
|
MRK
Merck & Co., Inc.
|
$376.37B | +44.9% | +1.3% | 122.0 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MDCX | -2.9% | -26.5% | -81.9% | -1.2% | -82.2% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -1.6% | -30.2% | -93.4% | -3.7% | -94.5% |